Accent Group Ltd (AX1)
Australian Securities Exchange · Australia · prices in AUD · close of 19 Oct 2026
Key indicators
| Last close | AUD 0.660 |
|---|---|
| 52-week range | 0.501 – 1.283 |
| Return, 1 month / 3 months | −0.8% / −7.4% |
| Return, 1 year / 3 years | −46.2% / −59.0% |
| Trend | Below its 200-day average |
| RSI (14) | 47 |
| Volatility (1 year) | 53.3% |
| Worst drawdown (1 year) | -59.0% |
| Average daily value traded | 0.80M AUD |
| Dividend yield | 6.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Accent Group is an Australian footwear retailer based in Melbourne. It runs chains of shoe shops across Australia and New Zealand, including athletic and lifestyle footwear banners, and sells through its stores and online channels. Its customers are everyday shoppers looking for branded sneakers, casual shoes and related accessories, and the company also distributes footwear brands to other retailers. Accent Group's business centres on retail store networks and digital sales of footwear and apparel.
The shares are listed on the Australian Securities Exchange in Australia under the code AX1, and the price on this page is in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Accent Group Ltd (AX1) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.660 on 19 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 741 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 46.2% and over the last three months it fell 7.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 51 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -9.2% | ||
| From 52-week high | -47.6% | ||
| Momentum | 50 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -7.4% | ||
| 6-month return | 8.3% | ||
| 12-month return, skipping the last month | -45.8% | ||
| Stability (higher is calmer) | 54 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 53.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -59.0% | ||
| Liquidity | 78 · Strong | Trades actively. | |
| Average daily value traded | 0.80M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 62 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 6.8% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +0.8% |
|---|---|
| 1 month | −0.8% |
| 3 months | −7.4% |
| 6 months | +8.3% |
| 1 year | −46.2% |
| 3 years | −59.0% |
| 5 years | −65.1% |
Signals
| 50-day / 200-day average | 0.681 / 0.727 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.013 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Aug 2026 | AUD 0.0125 |
| 3 Mar 2026 | AUD 0.0325 |
| 27 Aug 2025 | AUD 0.0150 |
| 5 Mar 2025 | AUD 0.0550 |
| 11 Sep 2024 | AUD 0.0450 |
| 6 Mar 2024 | AUD 0.0850 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.